| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $56,338,238 ) (Continued on the next page) |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R37AI136697 | Biochemistry of SAMHD1-mediated innate immunity responses | 001 | 6 | NIH | 5/14/2025 | $556,253 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30MH134482 | Identifying a critical developmental period for cognitive speed in a mouse model for neurodevelopmental disorders | 000 | 2 | NIH | 3/17/2025 | $41,812 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30MH134482 | Identifying a critical developmental period for cognitive speed in a mouse model for neurodevelopmental disorders | 001 | 2 | NIH | 3/20/2025 | $500 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01HD106285 | Pathological reprogramming of the m6A epitranscriptome in uterine fibroids | 001 | 5 | NIH | 4/24/2025 | $647,762 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA246807 | Radiation-induced senescence in the brain microenvironment: Implications for glioblastoma recurrence and therapy | 000 | 5 | NIH | 3/10/2025 | $321,049 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R00AG068239 | Impact of a Novel Secreted Enzyme J18 on Healthspan and Lifespan | 001 | 5 | NIH | 6/9/2025 | $19,920 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R00AG068239 | Impact of a Novel Secreted Enzyme J18 on Healthspan and Lifespan | 000 | 5 | NIH | 3/7/2025 | $224,100 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | U01CA283749 | The role of tumor-macrophage hybrid cells in prostate cancer metastasis | 001 | 2 | NIH | 5/29/2025 | $63,717 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | U01CA283749 | The role of tumor-macrophage hybrid cells in prostate cancer metastasis | 000 | 2 | NIH | 2/28/2025 | $573,451 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA293672 | Developing purinergic receptor inverse agonists for treating triple negative breast cancer | 000 | 1 | NIH | 2/24/2025 | $616,071 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG061729 | Sulfatide deficiency: A novel mechanism leading to reactive astrogliosis in aging and Alzheimer’s disease | 000 | 3 | NIH | 3/4/2025 | $571,995 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK097554 | Comparative Effectiveness of Two Initial Combination Therapies in Patients with New Onset Diabetes | 001 | 12 | NIH | 5/14/2025 | $68,490 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK097554 | Comparative Effectiveness of Two Initial Combination Therapies in Patients with New Onset Diabetes | 000 | 12 | NIH | 2/24/2025 | $616,424 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA244261 | Mechanistic characterization of the cell cycle-dependent DNA repair pathway- Resubmission | 001 | 6 | NIH | 5/22/2025 | $33,020 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA244261 | Mechanistic characterization of the cell cycle-dependent DNA repair pathway- Resubmission | 000 | 6 | NIH | 2/13/2025 | $297,176 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R37CA249305 | The role of NFIB-MAST1 signaling in mediating adaptive cisplatin resistance in SCLC | 000 | 6 | NIH | 2/13/2025 | $338,343 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R25DE032518 | Dental Research Intensive Program for Undergradate Students | 000 | 1 | NIH | 1/28/2025 | $134,934 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DA058018 | Gabapentinoid/opioid mixtures: abuse and toxicity | 001 | 3 | NIH | 4/8/2025 | $42,556 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DA058018 | Gabapentinoid/opioid mixtures: abuse and toxicity | 000 | 3 | NIH | 1/27/2025 | $383,014 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | UG3AG090675 | Building Unique Infrastructure for Large-scale Dementia research in French-Speaking Africa (BUILD-FSA) Project | 000 | 1 | NIH | 1/29/2025 | $487,386 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AI148641 | Development of a rapid, pan fungal diagnostic assay | 000 | 5 | NIH | 1/28/2025 | $452,461 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK140144 | Glycemic and Weight Loss Effects of Semaglutide in Subjects After Spinal Cord Injury and Type 2 Diabetes | 000 | 2 | NIH | 6/5/2025 | $694,221 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21AG087907 | The pathogenic effects of senescent cells on their microenvironments and their role in human brain aging | 000 | 2 | NIH | 5/29/2025 | $206,994 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG085545 | The role of sulfatide in the development of tauopathy in the context of ADRD | 000 | 2 | NIH | 5/29/2025 | $602,040 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DA005018 | Discriminative Stimulus Effects of Opioid Withdrawal | 001 | 36 | NIH | 4/7/2025 | $64,237 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DA005018 | Discriminative Stimulus Effects of Opioid Withdrawal | 000 | 36 | NIH | 12/20/2024 | $578,128 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21CA286307 | Development of Caspase Cleavage Targeting Chimeras (CACTACs) for Targeted Protein Cleavage | 000 | 2 | NIH | 11/1/2024 | $194,387 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R35GM153228 | Mechanisms of enhancer dynamics and assembly in gene regulation | 001 | 2 | NIH | 5/14/2025 | $387,508 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK128247 | The Regulation of Hepatic Metabolic Zonation by the Diabetes Gene TCF7L2 | 000 | 4 | NIH | 12/18/2024 | $440,457 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01NS131652 | CB1 receptors mediate metaplasticity in the cerebellar circuit | 000 | 2 | NIH | 11/22/2024 | $354,445 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30AI176699 | Macrophage NR4A nuclear receptors in tuberculosis pathogenesis | 000 | 2 | NIH | 12/12/2024 | $38,421 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA205224 | EEPD1 Repair of Stressed Replication Forks | 000 | 8 | NIH | 12/19/2024 | $348,750 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA279971 | Biomarkers For BRCA1-Deficient Cancers | 000 | 2 | NIH | 5/7/2025 | $436,807 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA205224 | EEPD1 Repair of Stressed Replication Forks | 001 | 8 | NIH | 5/29/2025 | $38,750 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA277498 | Novel approach of targeting AT-rich S/MAR regions for treating therapy resistant breast cancers | 000 | 3 | NIH | 4/22/2025 | $435,753 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK134637 | Adiponectin signaling and macrophage function | 000 | 3 | NIH | 5/30/2025 | $520,199 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA277498 | Novel approach of targeting AT-rich S/MAR regions for treating therapy resistant breast cancers | 001 | 3 | NIH | 5/22/2025 | $48,416 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AA031407 | Deciphering RNA Splicing Control of Lipid Metabolism and Alcoholic Liver Injury | 000 | 2 | NIH | 5/2/2025 | $505,745 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA281726 | Novel mechanism of chemokine nitration in bladder cancer | 000 | 2 | NIH | 4/17/2025 | $349,891 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG086271 | The role of paracrine growth factor signaling in thymus function and age-associated dysfunction | 000 | 2 | NIH | 4/10/2025 | $445,209 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG085531 | L-type calcium channels in Alzheimer’s disease pathophysiology | 000 | 2 | NIH | 5/7/2025 | $517,501 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA285299 | Therapeutic value and mechanistic action of PSPC1 in AML | 000 | 2 | NIH | 4/28/2025 | $540,338 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG086496 | The Hippo signaling pathway as a target of intervention for Alzheimer’s disease | 000 | 2 | NIH | 3/21/2025 | $485,560 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA285299 | Therapeutic value and mechanistic action of PSPC1 in AML | 001 | 2 | NIH | 5/23/2025 | $60,036 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA269866 | Development of Potent Estrogen Receptor Beta Agonists for Treating Glioblastoma | 000 | 3 | NIH | 12/13/2024 | $477,217 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG086496 | The Hippo signaling pathway as a target of intervention for Alzheimer’s disease | 001 | 2 | NIH | 6/10/2025 | $43,163 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA293655 | Structure and function of RAD51 paralog tumor suppressor complexes in genome maintenance | 000 | 2 | NIH | 4/21/2025 | $576,368 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30CA298683 | Novel Approach to Hepatocellular Carcinoma Treatment through Enhanced ER Stress | 002 | 1 | NIH | 5/22/2025 | $564 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30CA298683 | Novel Approach to Hepatocellular Carcinoma Treatment through Enhanced ER Stress | 001 | 1 | NIH | 3/12/2025 | $0 |
|
